3-Methyl-1H-pyrazol-4-amine dihydrochloride

Catalog No.: 
ACFMQI542
CAS No.: 
854698-16-1
Molecular Formula: 
C4H9Cl2N3
Molecular Weight: 
170.04
3-Methyl-1H-pyrazol-4-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$73.00InquiryInquiry
250mg95%$95.00InquiryInquiry
1g95%$176.00InquiryInquiry
5g95%$460.00InquiryInquiry
10g95%$648.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-1H-pyrazol-4-amine dihydrochloride
IUPAC Name3-methyl-1H-pyrazol-4-amine dihydrochloride
MDL No.MFCD18089291
Molecular FormulaC4H9Cl2N3
Molecular Weight170.04
SMILESNC1=CNN=C1C.[H]Cl.[H]Cl
InChI KeyQXNDZAPAEACKDJ-UHFFFAOYSA-N
Synonym5-Methyl-1H-pyrazol-4-aMine dihydrochloride (SALTDATA: 2HCl);5-methyl-1H-pyrazol-4-amine dihydrochloride;3-Methyl-1H-pyrazol-4-ylamine dihydrochloride;3-Methyl-1H-pyrazol-4-amine dihydrochloride
CAS No.854698-16-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFMQI542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRGIY108 route compound structure diagram
    ACRGIY1085334-39-4In Stock
  2. Then
  3. ACFMQI542 route product structure diagram
    ACFMQI542854698-16-1
Inquiry

2. ACFMQI542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFMQI542 route product structure diagram
    ACFMQI542854698-16-1
Inquiry

3. ACFMQI542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFMQI542 route product structure diagram
    ACFMQI542854698-16-1
Inquiry

Comments (0)